To further determine the potential role of PEA on the NLRP3 inflammasome pathway in MCD-treated NASH mice, we tested plasma IL-1β and IL-18 levels through ELISA assays. The gene discussed is IL18; the disease is metabolic dysfunction-associated steatohepatitis.